A patient has been diagnosed with acute pancreatitis. The nurse is addressing the diagnosis of Acute Pain Related to Pancreatitis. What pharmacologic intervention is most likely to be ordered for this patient?
A.
IV hydromorphone (Dilaudid)
B.
Oral naproxen (Aleve)
C.
IM meperidine (Demerol)
D.
Oral oxycodone
The Correct answer and Explanation is:
The correct answer is A. IV hydromorphone (Dilaudid).
Explanation:
Acute pancreatitis often leads to severe abdominal pain, which can be intense and debilitating. In managing this pain, the priority is to provide effective analgesia while considering the patient’s overall condition and any potential complications related to pancreatitis.
1. Severity of Pain in Acute Pancreatitis:
Patients with acute pancreatitis typically experience significant abdominal pain that may be described as constant and sharp, often radiating to the back. Effective pain management is crucial for comfort and can facilitate recovery.
2. Pharmacologic Interventions:
When it comes to pharmacologic interventions, opioids are the mainstay for treating severe pain associated with acute pancreatitis. IV hydromorphone (Dilaudid) is a potent opioid analgesic that is often preferred in acute settings due to its rapid onset of action and the ability to titrate the dose based on the patient’s pain level.
3. Comparison with Other Options:
- B. Oral naproxen (Aleve) is a nonsteroidal anti-inflammatory drug (NSAID) that is typically not effective for managing severe acute pain in hospital settings, particularly when the pain is severe and requires immediate relief.
- C. IM meperidine (Demerol) has fallen out of favor due to its side effects, including the risk of seizures from its metabolite. It is not recommended as a first-line option for pain management in pancreatitis.
- D. Oral oxycodone is another opioid, but it is not suitable for acute management in a hospital setting as it has a slower onset and is typically used for outpatient pain management or after stabilization.
4. Clinical Practice:
Administering IV hydromorphone allows for rapid titration to achieve pain control, which is essential in the acute care of a patient with pancreatitis. Additionally, while pain control is critical, healthcare providers will monitor the patient for any signs of complications from pancreatitis, ensuring a comprehensive approach to treatment.
In conclusion, IV hydromorphone (Dilaudid) is the most appropriate choice for managing acute pain in a patient with acute pancreatitis due to its efficacy and the urgent need for rapid pain relief.